Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Long-Term Deferred Tax (2016 - 2022)

Historic Long-Term Deferred Tax for Immucell (ICCC) over the last 12 years, with Q4 2022 value amounting to $665313.0.

  • Immucell's Long-Term Deferred Tax rose 75201.51% to $665313.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $665313.0, marking a year-over-year increase of 75201.51%. This contributed to the annual value of $665313.0 for FY2022, which is 75201.51% up from last year.
  • Immucell's Long-Term Deferred Tax amounted to $665313.0 in Q4 2022, which was up 75201.51% from $78087.0 recorded in Q4 2021.
  • In the past 5 years, Immucell's Long-Term Deferred Tax ranged from a high of $665313.0 in Q4 2022 and a low of $78087.0 during Q4 2021
  • For the 4-year period, Immucell's Long-Term Deferred Tax averaged around $450704.0, with its median value being $504236.0 (2018).
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first soared by 257565.44% in 2018, then tumbled by 8235.85% in 2021.
  • Quarter analysis of 4 years shows Immucell's Long-Term Deferred Tax stood at $563252.0 in 2018, then decreased by 21.41% to $442632.0 in 2020, then crashed by 82.36% to $78087.0 in 2021, then soared by 752.02% to $665313.0 in 2022.
  • Its Long-Term Deferred Tax was $665313.0 in Q4 2022, compared to $78087.0 in Q4 2021 and $442632.0 in Q4 2020.